How Island Pharmaceuticals Fast-Tracks a Game-Changing Antiviral Acquisition

middle.news 9:26am on Wednesday 9th of July, 2025 AEST • Pharmaceuticals Read Story

How Island Pharmaceuticals Fast-Tracks a Game-Changing Antiviral Acquisition

9:26am on Wednesday 9th of July, 2025 AEST Key Points Asset purchase agreement signed to acquire Galidesivir from BioCryst Galidesivir targets high-priority RNA viruses including Marburg and Ebola Potential regulatory approval via FDA’s Animal Rule requiring minimal additional trials Opportunity to secure a valuable Priority Review Voucher upon approval Read Story

middle. Tap to Read Tap the card to read the full analysis about Island Pharmaceuticals (ASX:ILA) OPEN ARTICLE